Cosmos Health’s subsidiary Cana Laboratories Values Manufacturing Pipeline at Over $20M
Cosmos Health estimates over $20 million in revenue across the lifetime of Cana Laboratories’ contract manufacturing agreements. Cosmos Health’s pipeline exceeds 32.7 million units across pharmaceutical and wellness products; it is not a supplement-only total. Cosmos Health said on September 28, 2026, that contract manufacturing agreements at its Cana Laboratories plant in Athens, Greece, represent […]